Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 1129448 10.3389/fphar.2022.1129448 Pharmacology Correction Corrigendum: Wuzi Yanzong pill—Based on network pharmacology and In Vivo evidence—Protects against spermatogenesis disorder via the regulation of the apoptosis pathway Chen et al. 10.3389/fphar.2022.1129448 Chen Wang-qiang 1 † Ding Cai-fei 1 † Yu Jia 1 Wang Chen-ye 1 Wan Ling-yi 1 Hu Hui-min 1 Ma Jian-xiong 1 2 3 * 1 Department of Reproductive Medicine, Zhejiang Provincial Integrated Chinese and Western Medicine Hospital, Hangzhou, China 2 The Second Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China 3 Department of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, China

Edited and reviewed by: Ke-Wu Zeng, Health Science Centre, Peking University, China

 *Correspondence: Jian-xiong Ma, reproductivedcf@sina.com

These authors have contributed equally to this work

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

 12 01 2023 2022 13 1129448 22 12 2022 28 12 2022 Copyright © 2023 Chen, Ding, Yu, Wang, Wan, Hu and Ma. 2023 Chen, Ding, Yu, Wang, Wan, Hu and Ma

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on Wuzi Yanzong pill—Based on network pharmacology and In Vivo evidence—Protects against spermatogenesis disorder via the regulation of the apoptosis pathway by Chen W, Ding C, Yu J, Wang C, Wan L, Hu H and Ma J (2020). Front. Pharmacol. 11:592827. doi: 10.3389/fphar.2020.592827 Wuzi Yanzong pill spermatogenesis disorder network pharmacology bioactive compounds hub targets apoptosis pathway

In the published article, there was an error in Figures 4, 6 as published. The images in Figure 4D and the immunohistochemical staining of Bcl-XL in Figure 6 were mistakenly swapped. The corrected Figures 4, 6 appear below.

Compounds identification and the effect of the WZYZP on the experimental spermatogenesis disorder model rats. (A) The phytochemical compositions identification in the WZYZP by UHPLC-Q-TOF/MS in the positive ion mode and negative ion mode. (B) Effect of the WZYZP on sperm counts and motility. (C) Effect of WZYZP on serum hormone levels of T, FSH levels were detected with an ELISA assay. (D) HE staining to evaluate the effect of the WZYZP on rat testes histological changes. Above, magnification ×200, 400. (E) TUNEL staining for the evaluation of cell apoptosis. Above, magnification ×200. #p < .05 vs. Model group, ##p < .01 vs. Model group.

Effect of the WZYZP on the expression levels of Bcl-XL and Bax in testes tissues. The expression levels of Bcl-XL and Bax in the testes were determined by immunohistochemistry analysis. Above, magnification ×200, 400. #p < .05 vs. Model group, ##p < .01 vs. Model group.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.